Picard Medical Inc
Research Picard Medical Inc (PMI) on Bullrun: market cap USD 23.31M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPMI
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 23.31M
- Financial periodQ2 2026
- RevenueUSD 2.95M
- Net income-USD 5.66M
- Free cash flow-USD 1.35M
- Gross margin20.9%
Valuation Snapshot
latest market cap is USD 23.31M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 4.94M | -USD 27.00M | -USD 15.67M | -4.1% | -0.75 | USD 7.45M | USD 6.98M | USD 3.79M |
| FY2024 | USD 4.39M | -USD 21.06M | -USD 11.87M | -2.6% | -2.99 | USD 96.00K | USD 20.93M | -USD 44.00M |
| FY2023 | USD 5.04M | -USD 15.57M | -USD 10.64M | -45.8% | -12.49 | USD 244.00K | USD 9.41M | -USD 3.55M |
| FY2022 | USD 4.11M | -USD 11.17M | -USD 10.75M | -121.3% | -8.79 | USD 152.00K | USD 1.96M | USD 11.37M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 23.31M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 128.98M | n/a | n/a | n/a |
About Picard Medical Inc
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Picard Medical Inc's market cap?
Picard Medical Inc's market capitalization is USD 23.31M.
What does Picard Medical Inc do?
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.